Source: LevelJump Healthcare Corp.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Leveljump Healthcare (JUMP) has appointed three new directors and one new advisory board member
  • Gary Prihar, Richard Jagodnik, and Jacki Glazer will join Leveljump’s board of Directors
  • Leveljump has also appointed Dr. Jonathan Chung to its advisory board
  • The new board members will lead Leveljump as the company looks to make more strategic acquisitions in the coming months
  • Leveljump Healthcare is a healthcare company with a focus on profitable telehealth solutions as well as primary care services in radiology
  • Shares in Leveljump Healthcare are steady, trading at $0.15 per share

Leveljump Healthcare (JUMP) has appointed three new directors and one new advisory board member.

Gary Prihar, Richard Jagodnik, and Jacki Glazer will join the Leveljump team on its board of directors as the company progresses towards its goal of organic growth.

Mr. Prihar will bring his extensive health care clinic experience to spearhead Leveljump’s advanced training in outreach, telemedicine, and expansive growth strategies. He has served as president and co-founder of Move Health & Wellness, president, CFO, and co-founder of Viva Care Medical and Telehealth, and senior consultant and board member of Lyte Medical.

Mr. Jagodnik has had over 10 years of audit experience, followed by 20 years of being a controller and CFO for private corporations. He is an alumnus of the John Molson School of Business at Concordia University with a major in accounting and received his CA designation in 1994.

Ms. Glazer has over 20 years of experience as a business partner and advisor on leadership teams in a number of industries. Her roles in public and private companies have allowed her to lead financing and operations through periods of acquisition-led growth.

The three new directors will lead Leveljump as the company looks to make more strategic acquisitions in the coming months. They join the team as Mr. Jeff Stevens and Ms. Sandy Hall announced their resignations from the company’s board of directors.

In addition to the new directors, Leveljump has appointed Dr. Jonathan Chung to its advisory board.

Dr. Chung is a radiologist with expertise in interventional radiology and teleradiology. He has extensive experience working in hospitals, acting as chief resident, and also serves as a lead radiologist for CTS.

Dr. Chung can assist Leveljump with radiology workflow, medical protocols, radiology practice expansion and other medical areas as needed.

“We are very pleased to welcome a number of new faces with extensive business, accounting and healthcare experience to our board of directors and our advisory board,” said Mitch Geisler, Leveljump CEO. “We feel that the new board, through its diversity and depth of business experience will be able to guide the company through its next phase of growth.”

Leveljump Healthcare is a healthcare company with a focus on profitable telehealth solutions as well as primary care services in radiology.

Shares in Leveljump Healthcare are steady, trading at $0.15 per share as of 3:45 pm EST.

More From The Market Herald

" Medicenna (TSX:MDNA) announces publication of MDNA11 preclinical data

Medicenna Therapeutics Corp. (MDNA) announced the publication of preclinical data on MDNA11.

" Clearmind Medicine (CSE:CMND) engages the Independent Trading Group as a market maker and Thunder11 as a PR agency

Clearmind Medicine Inc. (CMND) has engaged the services of Independent Trading Group to provide market-making services.

" Psyched Wellness (CSE:PSYC) provides update on study with the National Research Council of Canada

Psyched Wellness (PSYC) has released preliminary data from its study with the National Research Council of Canada (NRC).
codikoat, covid protection

" PharmaDrug (CSE:PHRX) begins manufacturing PD-001 for treatment of rare cancers and COVID-19

PharmaDrug (PHRX) has begun manufacturing PD-001, its oral formulation of cepharanthine, for cancer and infectious disease studies.